MedTrace Logo

Pharmacokinetics of Antiepileptics in Patients on CRRT

NCT03632915 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2021-10-05

No results posted yet for this study

Summary

The purpose of the study is to measure levels of any of the following AEDs (levetiracetam, phenobarbital, phenytoin, ketamine, valproic acid, lacosamide) in blood and effluent on critically ill patients receiving CRRT in order to characterize drug pharmacokinetics and optimize dosing strategies in patients on CRRT.

Conditions

Interventions

DRUG

Levetiracetam

Standard of care

DRUG

Lacosamide

Standard of care

DRUG

Phenytoin

Standard of care

DRUG

Phenobarbital

Standard of care

DRUG

Ketamine

Standard of care

DRUG

Valproic Acid

Standard of care

Sponsors & Collaborators

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Neeraj Badjatia, MD · University of Maryland, College Park

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-20
Primary Completion
2019-12-31
Completion
2019-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03632915 on ClinicalTrials.gov